High-dose of methylprednisolone in the surgical treatment of cervical spondylotic myelopathy in early stage

李锋,娄玉健,李光辉,熊伟,林杭,陈安民

DOI: https://doi.org/10.3969/j.issn.1004-406X.2006.z1.007

2006-01-01

Abstract:Objective:To investigate the effects of high-dose of methylprednisolone(MP) on the recovery of postoperative neurological functions due to cervical spondylotic myelopathy in early stage.Method:124 patients with cervical spondylotic myelopathy were treated with anterior decompression and fusion with autogeneous graft and plate fixation in our department.The candidate were the compressed area of spinal cord in transect≥25%.According to use of MP in the surgery or not,the patients were divided into the MP and the control group.60 cases were treated with MP(20mg/kg,iv) 30min prior to the decompression and then followed by 20% mannitol 250ml(iv,qd×3d) in the MP group.64 cases were treated with DXM 20mg 30min prior to the decompression and then 20% mannitol 250ml+DXM 10mg(iv,qd×3d) after operation in the control group.Early-stage(1 week) postoperative neurological function recovery rate were evaluated by the JOA scores.And complications of both groups were recorded.Result:Statistical analysis showed that there were no significant difference in the neurological function recovery rate between the two groups on the first or third day postoperatively(P>0.05). While compared with the control group,significant improvement of neurological function were found in the MP group on the 7th day after operation(P<0.05).No side-effect brought about by glucocorticoid occurred in the two groups.Conclusion:High-dose administration of MP just before the decompression surgery in patients with cervical spondylotic myelopathy can improve postoperative neurological function recovery rate significantly in early stage and the adminstration of MP mentioned above is safe.